ID   DHB8_RAT                Reviewed;         259 AA.
AC   Q6MGB5;
DT   11-SEP-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   02-OCT-2024, entry version 128.
DE   RecName: Full=(3R)-3-hydroxyacyl-CoA dehydrogenase;
DE            EC=1.1.1.n12 {ECO:0000250|UniProtKB:Q92506};
DE   AltName: Full=17-beta-hydroxysteroid dehydrogenase 8;
DE            Short=17-beta-HSD 8;
DE   AltName: Full=3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit {ECO:0000250|UniProtKB:Q92506};
DE            Short=KAR alpha subunit {ECO:0000250|UniProtKB:Q92506};
DE   AltName: Full=3-oxoacyl-[acyl-carrier-protein] reductase;
DE   AltName: Full=Estradiol 17-beta-dehydrogenase 8;
DE            EC=1.1.1.62 {ECO:0000250|UniProtKB:Q92506};
DE   AltName: Full=Testosterone 17-beta-dehydrogenase 8;
DE            EC=1.1.1.239 {ECO:0000250|UniProtKB:Q92506};
GN   Name=Hsd17b8;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15060004; DOI=10.1101/gr.1987704;
RA   Hurt P., Walter L., Sudbrak R., Klages S., Mueller I., Shiina T., Inoko H.,
RA   Lehrach H., Guenther E., Reinhardt R., Himmelbauer H.;
RT   "The genomic sequence and comparative analysis of the rat major
RT   histocompatibility complex.";
RL   Genome Res. 14:631-639(2004).
RN   [2]
RP   TISSUE SPECIFICITY.
RX   PubMed=9712896; DOI=10.1074/jbc.273.35.22664;
RA   Fomitcheva J., Baker M.E., Anderson E., Lee G.Y., Aziz N.;
RT   "Characterization of Ke 6, a new 17beta-hydroxysteroid dehydrogenase, and
RT   its expression in gonadal tissues.";
RL   J. Biol. Chem. 273:22664-22671(1998).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Required for the solubility and assembly of the
CC       heterotetramer 3-ketoacyl-[acyl carrier protein] (ACP) reductase
CC       functional complex (KAR or KAR1) that forms part of the mitochondrial
CC       fatty acid synthase (mtFAS). Alpha-subunit of the KAR complex that acts
CC       as scaffold protein required for the stability of carbonyl reductase
CC       type-4 (CBR4, beta-subunit of the KAR complex) and for its 3-ketoacyl-
CC       ACP reductase activity, thereby participating in mitochondrial fatty
CC       acid biosynthesis. Catalyzes the NAD-dependent conversion of (3R)-3-
CC       hydroxyacyl-CoA into 3-ketoacyl-CoA (3-oxoacyl-CoA) with no chain
CC       length preference; this enzymatic activity is not needed for the KAR
CC       function. Prefers (3R)-3-hydroxyacyl-CoA over (3S)-3-hydroxyacyl-CoA
CC       and displays enzymatic activity only in the presence of NAD(+).
CC       Cooperates with enoyl-CoA hydratase 1 in mitochondria, together they
CC       constitute an alternative route to the auxiliary enzyme pathways for
CC       the breakdown of Z-PUFA (cis polyunsaturated fatty acid) enoyl-esters.
CC       NAD-dependent 17-beta-hydroxysteroid dehydrogenase with highest
CC       activity towards estradiol (17beta-estradiol or E2). Has very low
CC       activity towards testosterone and dihydrotestosterone (17beta-hydroxy-
CC       5alpha-androstan-3-one). Primarily an oxidative enzyme, it can switch
CC       to a reductive mode determined in the appropriate physiologic milieu
CC       and catalyze the reduction of estrone (E1) to form biologically active
CC       17beta-estradiol. {ECO:0000250|UniProtKB:Q92506}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a (3R)-3-hydroxyacyl-CoA + NAD(+) = a 3-oxoacyl-CoA + H(+) +
CC         NADH; Xref=Rhea:RHEA:32711, ChEBI:CHEBI:15378, ChEBI:CHEBI:57319,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:90726;
CC         EC=1.1.1.n12; Evidence={ECO:0000250|UniProtKB:Q92506};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32712;
CC         Evidence={ECO:0000250|UniProtKB:Q92506};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol + NAD(+) = estrone + H(+) + NADH;
CC         Xref=Rhea:RHEA:24612, ChEBI:CHEBI:15378, ChEBI:CHEBI:16469,
CC         ChEBI:CHEBI:17263, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.62;
CC         Evidence={ECO:0000250|UniProtKB:Q92506};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24613;
CC         Evidence={ECO:0000250|UniProtKB:Q92506};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:24614;
CC         Evidence={ECO:0000250|UniProtKB:Q92506};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=NAD(+) + testosterone = androst-4-ene-3,17-dione + H(+) +
CC         NADH; Xref=Rhea:RHEA:14929, ChEBI:CHEBI:15378, ChEBI:CHEBI:16422,
CC         ChEBI:CHEBI:17347, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         EC=1.1.1.239; Evidence={ECO:0000250|UniProtKB:Q92506};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14930;
CC         Evidence={ECO:0000250|UniProtKB:Q92506};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-hydroxy-5alpha-androstan-3-one + NAD(+) = 5alpha-
CC         androstan-3,17-dione + H(+) + NADH; Xref=Rhea:RHEA:41992,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15994, ChEBI:CHEBI:16330,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         Evidence={ECO:0000250|UniProtKB:Q92506};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41993;
CC         Evidence={ECO:0000250|UniProtKB:Q92506};
CC   -!- PATHWAY: Steroid biosynthesis; estrogen biosynthesis.
CC       {ECO:0000250|UniProtKB:Q92506}.
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC       {ECO:0000250|UniProtKB:Q92506}.
CC   -!- PATHWAY: Lipid metabolism; mitochondrial fatty acid beta-oxidation.
CC       {ECO:0000250|UniProtKB:Q92506}.
CC   -!- SUBUNIT: Heterotetramer with CBR4; contains two molecules of HSD17B8
CC       and CBR4. {ECO:0000250|UniProtKB:Q92506}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix
CC       {ECO:0000250|UniProtKB:Q92506}.
CC   -!- TISSUE SPECIFICITY: Expressed in ovary at protein level.
CC       {ECO:0000269|PubMed:9712896}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX883042; CAE83931.1; -; Genomic_DNA.
DR   RefSeq; NP_997694.1; NM_212529.1.
DR   AlphaFoldDB; Q6MGB5; -.
DR   SMR; Q6MGB5; -.
DR   IntAct; Q6MGB5; 1.
DR   STRING; 10116.ENSRNOP00000000542; -.
DR   iPTMnet; Q6MGB5; -.
DR   PhosphoSitePlus; Q6MGB5; -.
DR   PaxDb; 10116-ENSRNOP00000000542; -.
DR   Ensembl; ENSRNOT00065000844; ENSRNOP00065000680; ENSRNOG00065000595.
DR   GeneID; 361802; -.
DR   KEGG; rno:361802; -.
DR   UCSC; RGD:1303158; rat.
DR   AGR; RGD:1303158; -.
DR   CTD; 7923; -.
DR   RGD; 1303158; Hsd17b8.
DR   eggNOG; KOG1200; Eukaryota.
DR   HOGENOM; CLU_010194_1_3_1; -.
DR   InParanoid; Q6MGB5; -.
DR   OrthoDB; 2263846at2759; -.
DR   PhylomeDB; Q6MGB5; -.
DR   TreeFam; TF313099; -.
DR   Reactome; R-RNO-75105; Fatty acyl-CoA biosynthesis.
DR   UniPathway; UPA00094; -.
DR   UniPathway; UPA00660; -.
DR   UniPathway; UPA00769; -.
DR   PRO; PR:Q6MGB5; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000000466; Expressed in ovary and 20 other cell types or tissues.
DR   ExpressionAtlas; Q6MGB5; baseline and differential.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005740; C:mitochondrial envelope; ISO:RGD.
DR   GO; GO:0005759; C:mitochondrial matrix; ISO:RGD.
DR   GO; GO:1990204; C:oxidoreductase complex; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0106386; F:(3R)-hydroxyacyl-CoA dehydrogenase (NAD+) activity; ISS:UniProtKB.
DR   GO; GO:0004303; F:estradiol 17-beta-dehydrogenase [NAD(P)+] activity; ISS:UniProtKB.
DR   GO; GO:0070404; F:NADH binding; ISS:UniProtKB.
DR   GO; GO:0047035; F:testosterone dehydrogenase (NAD+) activity; ISO:RGD.
DR   GO; GO:0008209; P:androgen metabolic process; ISO:RGD.
DR   GO; GO:0006703; P:estrogen biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0008210; P:estrogen metabolic process; ISO:RGD.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0051290; P:protein heterotetramerization; ISS:UniProtKB.
DR   CDD; cd05333; BKR_SDR_c; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR020904; Sc_DH/Rdtase_CS.
DR   InterPro; IPR002347; SDR_fam.
DR   PANTHER; PTHR42760:SF83; (3R)-3-HYDROXYACYL-COA DEHYDROGENASE; 1.
DR   PANTHER; PTHR42760; SHORT-CHAIN DEHYDROGENASES/REDUCTASES FAMILY MEMBER; 1.
DR   Pfam; PF13561; adh_short_C2; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   PRINTS; PR00080; SDRFAMILY.
DR   SMART; SM00822; PKS_KR; 1.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
DR   PROSITE; PS00061; ADH_SHORT; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Lipid biosynthesis; Lipid metabolism; Mitochondrion; NAD; Oxidoreductase;
KW   Phosphoprotein; Reference proteome; Steroid biosynthesis.
FT   CHAIN           1..259
FT                   /note="(3R)-3-hydroxyacyl-CoA dehydrogenase"
FT                   /id="PRO_0000304877"
FT   ACT_SITE        167
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10001"
FT   BINDING         13..21
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q92506"
FT   BINDING         40..41
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q92506"
FT   BINDING         72..74
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q92506"
FT   BINDING         154
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         167..171
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q92506"
FT   BINDING         200..202
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250|UniProtKB:Q92506"
FT   MOD_RES         58
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         66
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P50171"
FT   MOD_RES         158
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P50171"
FT   MOD_RES         171
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P50171"
SQ   SEQUENCE   259 AA;  26791 MW;  5E23ECCE525E6781 CRC64;
     MASQLRLRSA LALVTGAGSG IGRAISVRLA AEGAAVAACD LDGAAAQDTV RLLGNPGSED
     REPRGKHAAF QADVSEGPAA KRLLEQVQAC FFRPPSVVVS CAGITRDEFL LHMSEEDWDR
     VIAVNLKGTF LVTQAAAQAL VSSGGRGSII NISSIVGKVG NIGQTNYASS KAGVIGLTQT
     AARELGRHGI RCNSVLPGFI ATPMTQKMPE KVKDKVTAMI PLGHMGDPED VADVVAFLAS
     EDSGYITGAS VEVSGGLFM
//
